Bilypsa 4mg Tablets | 135-Count | POSACONAZOLE

🇮🇳 India Warehouse
POSACONAZOLE — 4mg per tablet, 135-count pack.
Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections.

Key warning: QT prolongation — caution with other QT drugs. Strong CYP3A4 inhibitor — multiple interactions. Hepatotoxicity monitoring. Suspension vs tablet have very different bioavailability characteristics.

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is Bilypsa 4mg (1X45) used for?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections.”}},{“@type”:”Question”,”name”:”What are the side effects of POSACONAZOLE?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Nausea, vomiting, diarrhea, headache, elevated liver enzymes, QT prolongation, hypokalemia.”}},{“@type”:”Question”,”name”:”Where does this ship from?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Ships from India Warehouse — international delivery worldwide.”}}]}

What is Bilypsa 4mg (1X45) (POSACONAZOLE)?

Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections.

How it Works

Inhibits fungal lanosterol 14-alpha-demethylase (CYP51), blocking ergosterol synthesis. Broadest spectrum of any oral azole — covers Zygomycetes (mucormycosis) unlike other azoles.

Quick Specs

Form Oral tablets — pre-dosed
Active Ingredient POSACONAZOLE
Dose per Tablet 4MG
Pack Size 135 tablets
Storage Room temperature (15–25°C), cool dry place
Shelf Life 2–3 years (properly stored)

Common Side Effects

Nausea, vomiting, diarrhea, headache, elevated liver enzymes, QT prolongation, hypokalemia.

Safety Warnings

⚠️ QT prolongation — caution with other QT drugs. Strong CYP3A4 inhibitor — multiple interactions. Hepatotoxicity monitoring. Suspension vs tablet have very different bioavailability characteristics.

🌏 International shipping: 7–14 days

Frequently asked questions

How does my subscription work?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

How do I edit what's in my plan?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Can I change my next delivery date?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

It's been a while since I took the quiz. Can I get a new recommendation?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Bilypsa 4mg Tablets | 135-Count | POSACONAZOLE”

Your email address will not be published. Required fields are marked *